For those who have tried oral supplements without meaningful improvement, IV therapy represents a practical next step worth discussing with a healthcare provider
Consequently, the growing obesity pipeline today comprises over 120 weight loss agents which are being developed by 60 companies across multiple mechanisms of action (MoAs) and different formulations, including many orals (see Figure 1)
Phase 3 clinical trial results released in May 2026 showed participants lost up to 28.3% of their body weight over 80 weeks, making it potentially more effective than semaglutide (Ozempic and Wegovy) and tirzepatide (Zepbound and Mounjaro)
Retatrutide Therapy A triple-action investigational peptide designed to interact with GLP-1, GIP, and glucagon receptors Your provider will review benefits, risks, and eligibility before recommending any treatment
Complimentary Consult FAQ Semaglutide FAQs You're Ready
Higher serum selenium was associated with significantly lower odds (OR (95 % CI)) of autoimmune thyroiditis (047 (035, 065)), hypothyroidism (075 (063, 090)), subclinical hypothyroidism (068 (058, 093)) and enlarged thyroid (075 (059, 097)) ( Reference Wu, Rayman and Lv 75 )